IUC26562-86

Abstract Code: IUC26562-86   Integrating Transcriptomic Profiles and Clinical Outcomes Across MEET-URO Risk Groups in Metastatic Renal Cell Carcinoma: A Comparative Analysis with the IMDC Framework Neola 1, N. Salgia 2, A. Moradi 2, S.E. Rebuzzi 3, P. Rescigno 4,...

IUC26559-92

Abstract Code: IUC26559-92   Reduced-Dose Pazopanib as First-Line Therapy in Metastatic Renal Cell Carcinoma: Real-World Evidence from an Immunotherapy-Inaccessible Cohort Krishnan M P 1, P. Shenoy 1, N. Devi R 1, A. Menon 1, S. Nawaz 1 (1) Divison of Medical...

IUC25693-90

Abstract Code: IUC25693-90   Real-world effectiveness of pembrolizumab plus axitinib in metastatic renal cell carcinoma in Panama Pinto 1, A. Cardenas 2 (1) Head of oncology Unit, Hospital Anita Moreno. Los Santos, Panama – Panama, (2) MD, Oncology Unit,...

IUC25517-85

Abstract Code: IUC25517-85   Title: First‑line TKI, ipilimumab–nivolumab, and lenvatinib–pembrolizumab in metastatic non–clear cell RCC: real‑world survival across two UK centres Maamoun 1, M. Al-Essa 2, I. Pedley 3, A. Azzabi 3, S. Grumett 2, M. Elgendy 3 (1)...

IUC25516-84

Abstract Code: IUC25516-84   Non clear renal cell carcinoma:  metastatic patterns and survival from a real‑world cohort Maamoun 1, M. Al-Essa 2, I. Pedley 3, A. Azzabi 3, S. Grumett 2, M. Elgendy 3 (1) Newcastle hospitals – United Kingdom, (2) Queen...
error: Content is protected !!